Expert Insights On Patient Recruitment

  1. Best Practices For Trial Design And Site Selection In Pediatric Clinical Trials 5/14/2024

    “Children are not small adults," reminds Katie Smentek, MD, a PI at Mankato Clinic. Here, Smentek shares her advice for designing trials and selecting sites for pediatric patients.

  2. Yes, Women's Exclusion In Clinical Trials Is Still A Problem 4/22/2024

    Despite the progress made in including women in clinical trials, challenges persist. Hera Biotech CEO Somer Baburek explains why the fight for inclusion isn't over.

  3. Considering The Patient Experience Is Critical To Creating A Successful ICF 4/19/2024

    If an ICF is not written with the patient in mind — so that it truly facilitates an informed consent — a clinical trial runs the risk of losing viable study participants and derailing study start-up, even success.

  4. $100M In Government Funding Helps, But What Can Really Be Done About Trial Diversity? 4/18/2024

    Breast surgical oncologist and medical director Monique Gary, DO lists three steps to take right now to improve clinical trial patient diversity.

  5. Latest CISCRP Patient Survey Reveals Diversity Gaps, Yields 5 Tips For Improvement 3/20/2024

    Results from the latest CISCRP “Perceptions & Insights” study reveal five opportunities to improve clinical trial recruitment and participation, especially among ethnic and racial minority groups.

  6. Informed Consent In Clinical Trials: Understanding The FDA's And OHRP's Joint Draft Guidance 3/18/2024

    The FDA and OHRP have jointly issued a new draft guidance about how sponsors, investigators, and IRBs should structure and present informed consent documents to clinical research participants.

  7. Community-Driven Registries Drive Understanding Of Rare Diseases 3/8/2024

    In an effort to increase and diversify research, the Pulmonary Fibrosis Foundation (PFF) envisioned a new approach to aggregating usable medical data — asking patients directly.

  8. Is Ignoring Gender Non-Conformity Research Holding Us Back? 3/4/2024

    Including individuals across the gender spectrum in clinical trials isn't just the right thing to do, it's also strategic move with benefits for science, society, and business.

  9. Tokenism In Clinical Trials For Rare Disease Patients 2/29/2024

    While recent efforts promote diversity in clinical trials, the lack of enforcement and tokenistic approaches risk leaving people of color behind. This article delves into the urgency of addressing this crisis and building genuine inclusivity for a healthier future for all.

  10. Addressing Underrepresentation In Cancer Trials: A Q&A With Stand Up To Cancer & Triage Cancer 2/13/2024

    Clinical Leader heard from both sides of the collaboration — SU2C researcher Dr. Chanita Hughes-Halbert, Ph.D., and grant recipient Triage Cancer co-founder and COO Monica Fawzy Bryant, Esq. — to explore each’s efforts to together bring health equity to those diagnosed with cancer.